Display options
Cite
Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin. Genes Nutr. 2015;10(3):460doi: 10.1007/s12263-015-0460-8.
Catalán, V., Gómez-Ambrosi, J., Rodríguez, A., Ramírez, B., Valentí, V., Moncada, R., Silva, C., Salvador, J., & Frühbeck, G. (2015). Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin. Genes & nutrition, 10(3), 460. https://doi.org/10.1007/s12263-015-0460-8
Catalán, Victoria, et al. "Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin." Genes & nutrition vol. 10,3 (2015): 460. doi: https://doi.org/10.1007/s12263-015-0460-8
Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Valentí V, Moncada R, Silva C, Salvador J, Frühbeck G. Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin. Genes Nutr. 2015 May;10(3):460. doi: 10.1007/s12263-015-0460-8. Epub 2015 Apr 14. PMID: 25869413; PMCID: PMC4395559.
Copy Download .nbib Format: NLM
Share it on

Genes Nutr. 2015 May;10(3):460. doi: 10.1007/s12263-015-0460-8. Epub 2015 Apr 14.

Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin.

Genes & nutrition

Victoria Catalán, Javier Gómez-Ambrosi, Amaia Rodríguez, Beatriz Ramírez, Víctor Valentí, Rafael Moncada, Camilo Silva, Javier Salvador, Gema Frühbeck

Affiliations

  1. Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain, [email protected].

PMID: 25869413 PMCID: PMC4395559 DOI: 10.1007/s12263-015-0460-8

Abstract

Inflammation is a critical contributor to the pathogenesis of metabolic disorders with adipose tissue being crucial in the inflammatory response by releasing multiple adipokines with either pro- or anti-inflammatory activities with potential functions as metabolic regulators. Peripheral blood mononuclear cells (PBMC) have been proposed as representative of the inflammatory status in obesity. The aim of the present study was to evaluate the contribution of PBMC to the obesity-associated chronic inflammation analyzing the expression of novel adipokines. Samples obtained from 69 subjects were used in the study. Real-time PCR determinations were performed to quantify gene expression levels in PBMC of novel adipokines including chemerin, chitinase-3-like protein 1 (YKL-40), lipocalin-2 (LCN-2) and osteopontin (OPN), and their circulating concentrations were also determined by ELISA. We show, for the first time, that PBMC gene expression levels of chemerin (P < 0.0001), chitinase-3-like protein 1 (P = 0.010), lipocalin-2 (P < 0.0001) and osteopontin (P < 0.0001) were strongly upregulated in obesity independently of the glycemic state. Circulating concentrations of these adipokines followed the same trend being significantly higher (P < 0.05) in obese normoglycemic and type 2 diabetic patients compared to lean volunteers and also associated (P < 0.05) with their corresponding mRNA levels in PBMC. These results provide evidence that alterations in inflammation-related adipokines are manifest in PBMC, which might contribute to the low-grade chronic inflammation that characterizes obesity.

References

  1. Clin Exp Immunol. 2006 Oct;146(1):39-46 - PubMed
  2. Nat Rev Immunol. 2011 Feb;11(2):85-97 - PubMed
  3. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90 - PubMed
  4. Diabetes Res Clin Pract. 2014 Aug;105(2):141-50 - PubMed
  5. J Exp Med. 2008 Apr 14;205(4):767-75 - PubMed
  6. J Clin Endocrinol Metab. 2014 Jan;99(1):E53-61 - PubMed
  7. Obesity (Silver Spring). 2013 Mar;21(3):461-8 - PubMed
  8. J Clin Endocrinol Metab. 2000 Sep;85(9):3338-42 - PubMed
  9. FASEB J. 2004 Jan;18(1):215-7 - PubMed
  10. Biochem Biophys Res Commun. 2013 Apr 19;433(4):450-5 - PubMed
  11. Diabetologia. 2008 Nov;51(11):2060-7 - PubMed
  12. J Clin Endocrinol Metab. 2007 Sep;92(9):3719-27 - PubMed
  13. Obes Facts. 2013;6(2):146-51 - PubMed
  14. Diabetes. 2002 Feb;51(2):455-61 - PubMed
  15. Clin Endocrinol (Oxf). 2010 Mar;72(3):342-8 - PubMed
  16. Annu Rev Physiol. 2010;72:219-46 - PubMed
  17. Clin Chim Acta. 2013 Apr 18;419:87-94 - PubMed
  18. Obes Surg. 2007 Nov;17(11):1464-74 - PubMed
  19. Int J Obes (Lond). 2012 Feb;36(2):286-94 - PubMed
  20. Metabolism. 2008 Feb;57(2):192-9 - PubMed
  21. Surg Obes Relat Dis. 2013 Mar-Apr;9(2):306-14 - PubMed
  22. J Clin Invest. 2003 Dec;112(12):1821-30 - PubMed
  23. Eur Respir J. 2007 Aug;30(2):223-31 - PubMed
  24. Obes Surg. 2009 Nov;19(11):1557-63 - PubMed
  25. Diabetes Care. 2014 Oct;37(10):2813-21 - PubMed
  26. Diabetes. 2010 Apr;59(4):935-46 - PubMed
  27. Horm Metab Res. 2007 Jul;39(7):495-500 - PubMed
  28. Obes Surg. 2006 Mar;16(3):251-7 - PubMed
  29. Nat Med. 2009 Aug;15(8):930-9 - PubMed
  30. Mol Endocrinol. 2014 Oct;28(10 ):1616-28 - PubMed
  31. Clin Chem. 2009 Apr;55(4):611-22 - PubMed
  32. Obes Facts. 2013;6(2):117-20 - PubMed
  33. J Mol Med (Berl). 2009 Aug;87(8):803-13 - PubMed
  34. J Clin Invest. 2003 Dec;112(12):1796-808 - PubMed
  35. Mol Metab. 2014 Mar 22;3(4):384-93 - PubMed
  36. Cell. 2013 Feb 14;152(4):673-84 - PubMed
  37. Diabetes Care. 2009 Jan;32(1):129-31 - PubMed
  38. Lancet. 2014 Aug 30;384(9945):766-81 - PubMed
  39. J Hepatol. 2000 Jun;32(6):911-20 - PubMed
  40. Cell. 2008 May 30;133(5):775-87 - PubMed
  41. Clin Endocrinol (Oxf). 2014 Oct;81(4):536-41 - PubMed
  42. PLoS One. 2014 May 28;9(5):e98398 - PubMed
  43. Mol Nutr Food Res. 2012 Jul;56(7):1160-72 - PubMed
  44. Endocrinology. 2007 Oct;148(10):4687-94 - PubMed
  45. J Clin Invest. 2007 Jan;117(1):175-84 - PubMed
  46. J Clin Invest. 2011 Jun;121(6):2111-7 - PubMed
  47. Nature. 2004 Dec 16;432(7019):917-21 - PubMed
  48. Circulation. 2004 Sep 21;110(12 ):1564-71 - PubMed
  49. Mol Endocrinol. 2008 Jun;22(6):1416-26 - PubMed
  50. Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):972-8 - PubMed
  51. PLoS One. 2012;7(10):e47377 - PubMed
  52. Genes Nutr. 2013 Jul;8(4):425-34 - PubMed
  53. Diabetologia. 2003 Feb;46(2):143-72 - PubMed
  54. Eur Cytokine Netw. 2004 Jan-Mar;15(1):60-6 - PubMed
  55. J Clin Endocrinol Metab. 2011 Jan;96(1):200-9 - PubMed
  56. Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R1-7 - PubMed
  57. Obes Surg. 2006 Mar;16(3):262-9 - PubMed
  58. J Clin Endocrinol Metab. 2012 Apr;97(4):E556-64 - PubMed
  59. Rev Endocr Metab Disord. 2014 Dec;15(4):277-87 - PubMed
  60. Nat Rev Endocrinol. 2012 Oct;8(10):570-2 - PubMed

Publication Types